Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia

Leukemia

Volumn 13, Issue 1, 1999, Pages 38-43

  Iwai, T ^b   Yokota, S ^a   Nakao, M ^b   Okamoto, T ^b   Taniwaki, M ^b   Onodera, N ^b   Watanabe, A ^b   Kikuta, A ^b   Tanaka, A ^b   Asami, K ^b   Sekine, I ^b   Mugishima, H ^b   Nishimura, Y ^b   Koizumi, S ^b   Horikoshi, Y ^b   Mimaya, J ^b   Ohta, S ^b   Nishikawa, K ^b   Iwai, A ^b   Shimokawa, T ^b   Nakayama, M ^b   Kawakami, K ^b   Gushiken, T ^b   Hyakuna, N ^b   Katano, N ^b   Tsurusawa, M ^b   Fujimoto, T ^b   more..

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NONE

Author keywords

AML; Child; FLT3; Prognosis; Tandem duplication

Indexed keywords

PROTEIN TYROSINE KINASE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; FEMALE; GENE DUPLICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

EID: 0032931560     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401241     Document Type: Article

References (28)

1. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 1991; 65: 1143-1152.
2. Rosnet O, Schiff C, Pebusque MJ, Marchetto S, Tonnelle C, Toiron Y, Birg F, Birnbaum D. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 1993; 81: 1110-1119.
3. Lyman SD, Jacobson SEW. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 1998; 91: 1101-1134.
4. Brasel K, Escobar S, Anderberg R, de Vries P, Gruss HJ, Lyman SD. Expression of the flt3 receptor and its ligand on hematopoietic cells. Leukemia 1995; 9: 1212-1218.
5. Drexler HG. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Leukemia 1996; 10: 588-599.
6. Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, Sonoda Y, Fujimoto T, Misawa S. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 1996; 10: 1911-1918.
7. Yokota S, Kiyoi H, Nakao M, Iwai T, Misawa S, Okuda T, Sonoda Y, Abe T, Kashima K, Matsuo Y, Naoe T. Internal tandem duplication in the juxtamembrane domain of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies - a study on a large series of patients and cell lines. Leukemia 1997; 11: 1605-1609.
8. Iwai T, Yokota S, Nakao M, Kaneko H, Nakai H, Kashima K, Misawa S. Tandem duplication in the juxtamembrane domain of the flt3 gene is not involved in blastic crisis of chronic myeloid leukemia. Leukemia 1997; 11: 1992-1993.
9. Horiike S, Yokota S, Nakao M, Iwai T, Sasai Y, Kaneko H, Taniwaki M, Kashima K, Fujii H, Abe T, Misawa S. Tandem duplication of the FLT3 receptor gene is closely associated with leukemic transformation of myelodysplasia. Leukemia 1997; 11: 1442-1446.
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 626-629.
11. Mimaya J, Horikoshi Y, Shimizu H, Maeda H, Koizumi S, Kawakami K, Watanabe A, Utsumi J, Kikuta A, Oka T, Mugishima H, Kawamura N, Gushiken T, Ohta S, Yamamura Y, Ishida Y, Sekine I, Okada N, Fujimoto T. Myelogenous leukemia in children. ANLL9205 study by Children's Cancer and Leukemia Study Group. Jpn J Clin Hematol 1997; 38: 100-107.
12. Tsurusawa M, Katano N, Hirota T, Mimaya J, Horikoshi Y, Kawamura N, Yanai M, Kamitamari A, Tsuji Y, Fujimoto T. Treatment results in childhood acute myeloblastic leukemia - a report of clinical trials of a past decade from the Japanese Children's Cancer and Leukemia Study Group. Jpn J Clin Hematol 1997; 38: 505-512.
13. Hirota T, Fujimoto T, Katano N, Tsurusawa M, Eguchi H, Nakadate N, Kamitamari K, Kawakami K, Nishikawa K, Asami K, Shirahata A, Koizumi S, Mugishima H, Gushiken T, Hyakuna N, Imaizumi M, Komatu K, Takitani K, Miyake M, Yanase T. Treatment results of intermittent and cycle regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group. Jpn J Clin Hematol 1997; 38: 1177-1182.
14. Yokota S, Hansen-Hagge TE, Ludwig WD, Reiter A, Raghavachar A, Kleihauer E, Bartram CR. Use of polymerase chain reaction to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 1991; 77: 331-339.
15. Grier HE, Gelber RD, Camitta BM, Delorey MJ, Link MP, Price KN, Leavitt PR, Weinstein HJ. Prognostic factors in childhood acute myelogenous leukemia. J Clin Oncol 1987; 5: 1026-1032.
16. Hurwitz CA, Schell MJ, Pui CH, Crist WM, Behm F, Mirro J Jr. Adverse prognostic feature in 251 children treated for acute myeloid leukemia. Med Pediatr Oncol 1993; 21: 1-7.
17. Ritter J, Vormoor J, Creutzig U, Schellong P. Prognostic significance of Auer rods in childhood acute myelogenous leukemia: results of the studies AML-BFM-78 and -83. Med Pediatr Oncol 1989; 17: 202-209.
18. Larson RA, Williams SF, Le Beau MM, Bitter MA, Vardiman JW, Rowley JD. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood 1986; 689: 1242-1249.
19. Kalwinsky DK, Raimondi SC, Schell MJ, Mirro J Jr, Santana VM, Behm F, Dahl GV, Williams D. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. J Clin Oncol 1990; 8: 75-83.
20. Swirsky DM, de Bastos M, Parish SE, Rees JK, Hayhoe FG. Features affecting outcome during remission induction of acute myeloid leukemia in 619 adult patients. Br J Haematol 1986; 64: 435-453.
21. Benedetto P, Mertelsmann R, Szatrowski TH, Andreeff M, Gee T, Arlin Z, Kempin S, Clarkson B. Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia. J Clin Oncol 1986; 4: 489-495.
22. Griffin JD, Davis R, Nelson DA, Davey FR, Mayer RJ, Sciffer C, McIntyre OR, Bloomfield CD. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia. Blood 1986; 68: 1232-1241.
23. Ball ED, Davis RB, Griffin JD, Mayer RJ, Davey FR, Arthur DC, Wurster-Hill D, Noll W, Elghetany MT, Allen SL, Rai K, Lee EJ, Sciffer CA, Bloomfield CD. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood 1991; 77: 2242-2250.
24. Raza A, Preisler HD, Day R, Yasin Z, White M, Lykins J, Kukla C, Barcos M, Bennett J, Browman G, Goldberg J, Grunwald H, Larson R, Vardiman J, Vogler R. Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup study. Blood 1990; 76: 2191-2197.
25. Zittoun R, Cadiou M, Bayle C, Suciu S, Solbu G, Hayat M. Prognostic value of cytologic parameters in acute myelogenous leukemia. Cancer 1984; 53: 1526-1532.
26. Billstrom R, Nilsson PG, Mitelman F. Chromosomes, Auer rods and prognosis in acute myeloid leukaemia. Eur J Haematol 1988; 40: 273-278.
27. Farr C, Gill R, Katz F, Gibbons B, Marshall CJ. Analysis of ras gene mutations in childhood myeloid leukaemia. Br J Haematol 1991; 77: 323-327.
28. Radich JP, Kopecky KJ, Willman CL, Weick J, Head A, Appelbaum F, Collins SJ. N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clonical significance. Blood 1990; 76: 801-807.